ReviewEndocrine, metabolic & immune disorders drug targets2022
Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
Yogesh Garg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it